Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.6B |
| 2 |
American Express
AXP
|
+$398M |
| 3 |
Capital One
COF
|
+$151M |
| 4 |
Apollo Global Management
APO
|
+$111M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$109M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
Amazon
AMZN
|
+$403M |
| 4 |
NVIDIA
NVDA
|
+$356M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$283M |
Sector Composition
| 1 | Technology | 30.21% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.22% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Rhythm Pharmaceuticals
RYTM
$6.5B
| $1.63M | ﹤0.01% |
98,800
+1,500
| +2% | +$24.7K |
|
2027
MarineMax
HZO
$573M
| $1.63M | ﹤0.01% |
47,600
+700
| +1% | +$23.9K |
|
|
HUT
2028
Hut 8
HUT
$3.37B
| $1.62M | ﹤0.01% |
+97,560
| New | +$1.62M |
|
2029
Collegium Pharmaceutical
COLL
$1.23B
| $1.62M | ﹤0.01% |
75,300
+6,400
| +9% | +$138K |
|
|
NNDM
2030
Nano Dimension
NNDM
$319M
| $1.62M | ﹤0.01% |
559,700
| – | – |
|
2031
Regenxbio
RGNX
$479M
| $1.61M | ﹤0.01% |
80,500
+1,100
| +1% | +$22K |
|
2032
ADMA Biologics
ADMA
$3.84B
| $1.61M | ﹤0.01% |
435,500
+12,500
| +3% | +$46.1K |
|
|
CHUY
2033
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $1.6M | ﹤0.01% |
39,200
+400
| +1% | +$16.3K |
|
2034
IMAX
IMAX
$1.71B
| $1.6M | ﹤0.01% |
94,000
-2,600
| -3% | -$44.2K |
|
2035
CRA International
CRAI
$1.31B
| $1.59M | ﹤0.01% |
15,600
+200
| +1% | +$20.4K |
|
2036
Usana Health Sciences
USNA
$564M
| $1.59M | ﹤0.01% |
25,200
+300
| +1% | +$18.9K |
|
2037
Standard Motor Products
SMP
$901M
| $1.59M | ﹤0.01% |
42,300
+400
| +1% | +$15K |
|
|
SHYF
2038
DELISTED
The Shyft Group
SHYF
| $1.59M | ﹤0.01% |
71,900
| – | – |
|
2039
Sonic Automotive
SAH
$2.83B
| $1.58M | ﹤0.01% |
33,200
-6,500
| -16% | -$310K |
|
2040
Trupanion
TRUP
$1.87B
| $1.58M | ﹤0.01% |
80,410
+5,400
| +7% | +$106K |
|
2041
JetBlue
JBLU
$1.89B
| $1.58M | ﹤0.01% |
178,500
+3,700
| +2% | +$32.8K |
|
|
DCBO
2042
Docebo
DCBO
$867M
| $1.58M | ﹤0.01% |
39,900
+500
| +1% | +$19.8K |
|
|
RWT
2043
Redwood Trust
RWT
$802M
| $1.58M | ﹤0.01% |
247,600
+2,900
| +1% | +$18.5K |
|
|
FBMS
2044
DELISTED
The First Bancshares, Inc.
FBMS
| $1.57M | ﹤0.01% |
60,930
+11,600
| +24% | +$300K |
|
|
SII
2045
Sprott
SII
$1.78B
| $1.57M | ﹤0.01% |
48,575
+600
| +1% | +$19.4K |
|
|
PGRE
2046
Paramount Group
PGRE
$1.59B
| $1.57M | ﹤0.01% |
354,643
-24,900
| -7% | -$110K |
|
2047
The Beauty Health Co
SKIN
$313M
| $1.57M | ﹤0.01% |
187,500
+2,100
| +1% | +$17.6K |
|
2048
TORM
TRMD
$2.16B
| $1.56M | ﹤0.01% |
64,971
+2,264
| +4% | +$54.5K |
|
|
TWKS
2049
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $1.56M | ﹤0.01% |
+207,000
| New | +$1.56M |
|
2050
PubMatic
PUBM
$390M
| $1.56M | ﹤0.01% |
85,400
-3,100
| -4% | -$56.7K |
|